See the DrugPatentWatch profile for Abreva
Docosanol, marketed under the brand name Abreva, is an over-the-counter topical antiviral medication used to treat cold sores caused by the herpes simplex virus [1][2]. It works by inhibiting the fusion of the herpes simplex virus with the host cell membrane, thereby preventing the virus from entering healthy cells and replicating [1][3].
How does Abreva work to treat cold sores?
Abreva's active ingredient, docosanol, functions by interfering with the ability of the herpes simplex virus to fuse with the host cell membrane [1][3]. This process is crucial for the virus to enter healthy cells and spread [1]. By blocking this fusion, docosanol aims to prevent the virus from replicating and spreading further, which can help shorten the healing time of cold sores [1][3].
How long does it take for Abreva to work?
When applied at the first sign of a cold sore, Abreva can shorten the healing time by approximately one day [1][4]. Consistent application as directed is important for optimal results [1].
Can Abreva prevent cold sores from returning?
Abreva is intended for the treatment of active cold sores, not for preventing their recurrence [1]. It does not cure the herpes simplex virus infection, which remains in the body [1].
Where can I buy Abreva?
Abreva is available over-the-counter at most pharmacies, drugstores, and mass retailers [1].
What are the side effects of Abreva?
The most common side effects reported with Abreva include headache, application site pain, and rash [2]. Serious side effects are rare [2].
How does docosanol compare to other cold sore treatments?
Other cold sore treatments include prescription antiviral medications like acyclovir, valacyclovir, and famciclovir, which are taken orally or applied topically [5]. These prescription drugs also work by inhibiting viral DNA replication [5]. Over-the-counter options may include topical anesthetics for pain relief or homeopathic remedies, though their efficacy varies [6]. Abreva's mechanism of action, inhibiting viral fusion, distinguishes it from some other antivirals [1][5].
When does the patent for Abreva expire?
Information regarding the specific patent expiry for Abreva's active ingredient, docosanol, is not readily available in the provided context. DrugPatentWatch.com is a resource for tracking pharmaceutical patents [7].
Sources:
[1] https://www.abreva.com/
[2] https://www.webmd.com/drugs/2/drug-163701/abreva-topical
[3] https://www.rxlist.com/abreva-drug.htm
[4] https://www.cvs.com/shop/abreva-cold-sore-cream-prodid-348483
[5] https://www.mayoclinic.org/diseases-conditions/cold-sore/diagnosis-treatment/drc-20371023
[6] https://www.nhs.uk/conditions/cold-sores/treatment/
[7] https://drugpatentwatch.com/